Showing 881-890 of 987 results for "".
- Aquavit's Neurotoxin Submitted to FDAhttps://modernaesthetics.com/news/aquavits-neurotoxin-submitted-to-fda/2473213/Aquavit Pharmaceuticals, Inc. has submitted its IND for a new botulinum toxin (DTX-021) to the FDA for approval. The company also unveiled its development programs at the Annual meeting of the American Academy of Dermatology in Boston. DTX-021, a botulinum toxin type A drug intende
- Cynosure and Jeisys Medical Japan Expand Partnershiphttps://modernaesthetics.com/news/cynosure-and-jeisys-medical-japan-expand-partnership/2473209/Cynosure LLC’s subsidiary Cynosure KK has entered into a distribution partnership with Jeisys Medical KK, a subsidiary of Jeisys Medical Inc. in Japan. Under the terms of the agreement, Jeisys Medical will have exclusive distribution rights for products within Cynosure&
- Endo Launches New Consumer Campaign for Qwohttps://modernaesthetics.com/news/endo-launches-new-consumer-campaign-for-qwo/2473202/Endo International plc is kicking off more than 200 patient events across the United States as part of Butt First, a new direct-to-consumer awareness campaign about Qwo (collagenase clostridium histolyticum-aaes). Qwo received FDA approval in Jul
- ASDS Survey: Most Dermatology Practices Still Coping with COVID-19https://modernaesthetics.com/news/asds-survey-most-derm-practices-still-coping-with-covid-19/2473193/From dramatic upticks in the use of teledermatology to staffing challenges and delays in procedures, the ongoing COVID-19 pandemic continues to affect dermatology practices and patients, according to a
- FDA Approves Mentor MemoryGel BOOST Breast Implanthttps://modernaesthetics.com/news/fda-approves-mentor-memorygel-boost-breast-implant/2473184/The Mentor® MemoryGel BOOST™ Breast Implant is now FDA approved for breast augmentation in women at least 22-years-old, and for women of all ages undergoing breast reconstruction. The product from Me
- BTL Announces New EMFACE Facial Devicehttps://modernaesthetics.com/news/btl-announces-new-emface-facial-device/2473183/BTL has announced its latest technology innovation, which the company says is the result of combining many years of institutional knowledge of the simultaneous emission of radio frequency and electromagnetic energies. EMFACE™ utilizes a patented technology of muscle contraction and ski
- Business News: $511M SPAC Merger Deal for Sunevahttps://modernaesthetics.com/news/business-news-511m-spac-merger-deal-for-suneva/2473182/Suneva Medical, Inc. and Viveon Health Acquisition Corp., a special purpose acquisition company (SPAC), are joining forces to form a regenerative aesthetics company. Upon completion of the transaction, the combined company's securities are expected to be traded on the NYSE unde
- Does the "No Surprises Act" Apply to Aesthetic Services?https://modernaesthetics.com/news/does-the-no-surprises-act-apply-to-aesthetic-services/2473180/In a chat thread with colleagues on our mutual trade organizations' message board, there was a question about providing Good Faith Estimates (GFE) for aesthetic procedures under the No Surprises Act. I stated that I didn't think GFEs were required for aesthetic procedures, but a represent
- Obagi Rolls Out The Skintrinsiq System Devicehttps://modernaesthetics.com/news/obagi-rolls-out-the-skintrinsiq-system-device/2473178/Obagi is launching the Skintrinsiq device, its first entry into the complementary skincare device market. The Skintrinsiq system extracts impurities then infuses Obagi skincare products via treatment protocols customized for individual skincare needs. "The uni
- Allergan Aesthetics Completes Soliton Acquisition, Adds Resonic to Portfoliohttps://modernaesthetics.com/news/allergan-aesthetics-completes-soliton-acquisition-adds-resonic-to-portfolio/2473176/It’s official. Allergan Aesthetics, an AbbVie company, completed its acquisition of Soliton, Inc. The addition of Soliton and its technology complements Allergan Aesthetics' portfolio of non-invasive body contouring treatments to now include the RES